Montelukast For Adolescents And Adults From 15 Years Pharmathen (Montelukast)

Montelukast blocks the cysteinyl leukotriene receptor CysLT1, preventing leukotrienes D4, C4 and E4 from binding. This inhibition reduces bronchoconstriction, airway inflammation and mucus production, helping to keep the airways open and less reactive.

The specific dose and dosing schedule are determined by the prescribing healthcare professional based on the patient’s age, condition severity and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Montelukast in pregnancy are limited, and it should only be used if the potential benefit justifies any potential risk to the fetus. Limited information is available for lactating women; therefore, a healthcare provider should evaluate the risk‑benefit ratio before use.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Montelukast is a leukotriene receptor antagonist and is generally used as an add‑on therapy or alternative for patients who cannot tolerate inhaled corticosteroids. Inhaled corticosteroids target a broader range of inflammatory pathways, while Montelukast specifically blocks leukotriene‑mediated effects, offering a different safety and side‑effect profile.

Montelukast tablets should be stored at temperatures below 25 °C, in their original packaging, and protected from moisture and direct sunlight. Keeping the product in a dry, cool place helps maintain its stability and potency.

Montelukast is taken orally, usually as a single tablet taken once daily in the evening with or without food. The exact timing and whether it should be taken with meals are determined by the prescribing clinician.

Serious risks include rare but severe allergic reactions such as rash, angioedema or anaphylaxis, and neuropsychiatric events like depression, mood changes or suicidal thoughts. Patients should be monitored for these symptoms and seek immediate medical attention if they occur.

Montelukast should be avoided in individuals with a known hypersensitivity to the drug or any of its excipients. It is also contraindicated in patients who have experienced severe allergic reactions to leukotriene receptor antagonists.